Antonio Mulero-Sánchez

4PUBLICATIONS
64CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Molecular targetsCheminformatics and quantitative structure-activity relationships
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (4)

|Dec 03, 2025
Palbociclib, Trastuzumab, and Endocrine Therapy in Pretreated HER2-Positive and PAM50 Luminal Advanced Breast Cancer: Randomized Phase II, SOLTI-1303 PATRICIA Trial.

Eva Ciruelos, Tomás Pascual, Guillermo Villacampa

|Mar 27, 2024
Paradoxical Activation of Oncogenic Signaling as a Cancer Treatment Strategy.

Matheus Henrique Dias, Anoek Friskes, Siying Wang

|Jan 18, 2023
Rational combination of SHP2 and mTOR inhibition for the treatment of hepatocellular carcinoma.

Antonio Mulero-Sánchez, Christel F A Ramirez, Aimée du Chatinier

|May 09, 2022
Genetic and compound screens uncover factors modulating cancer cell response to indisulam.

Ziva Pogacar, Kelvin Groot, Fleur Jochems

Pageof 1